We gathered 15 paired (primary and an involved lymph node) excised breast tumors of different molecular subtypes (HER2+, triple negative, luminal A and luminal B HER2−), from the National Research Institute of Oncology, Krakow (Poland) Branch. This evidence concerns the gene ERBB2 and breast neoplasm.